{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:59Z","timestamp":1789635779506,"version":"4.0.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.actatropica.2026.108266","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:38:19Z","timestamp":1785512299000},"page":"108266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neutralizing dengue antibodies after 10 years of the chimeric yellow fever tetravalent dengue vaccine (CYD-TDV) and dengue antibody cross-reactivity with SARS-CoV-2 in Indonesia"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-9403","authenticated-orcid":false,"given":"Mulya Rahma","family":"Karyanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hindra Irawan","family":"Satari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Rezeki","family":"Hadinegoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anggraini","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indah Suci","family":"Widyahening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakiudin","family":"Munasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-2590","authenticated-orcid":false,"given":"R\u2024Tedjo","family":"Sasmono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2026.108266_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008676","article-title":"Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine","volume":"14","author":"Ahmed","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108266_bib0002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2026.108266_bib0004","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.actatropica.2026.108266_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trivac.2015.03.002","article-title":"Immunogenicity and safety of a tetravalent dengue vaccine during a five-year follow-up period","volume":"4","author":"Capeding","year":"2015","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.actatropica.2026.108266_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.actatropica.2026.108266_bib0007","article-title":"A case-control study to determine the effectiveness of a tetravalent dengue vaccine in the state of Paran\u00e1, Brazil","volume":"7","author":"de Moraes","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.actatropica.2026.108266_bib0008","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/ciab288","article-title":"Analysis of hospitalized and severe dengue cases over the 6 years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America","volume":"73","author":"Forrat","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108266_bib0009","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2026.108266_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cid\/ciab282","article-title":"Is Dengue vaccine protection possible?","volume":"74","author":"Halstead","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108266_bib0012","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals","volume":"215","author":"Henein","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.actatropica.2026.108266_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147066","article-title":"Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection","volume":"131","author":"Henein","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actatropica.2026.108266_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840104","article-title":"Current development and challenges of tetravalent live-attenuated dengue vaccines","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2026.108266_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1724625","article-title":"SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo","volume":"16","author":"Jakhar","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2026.108266_bib0015","doi-asserted-by":"crossref","first-page":"e2444","DOI":"10.1093\/cid\/ciaa1207","article-title":"Potential antigenic cross-reactivity between severe acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue viruses","volume":"73","author":"Lustig","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108266_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12929-022-00833-y","article-title":"Dengue and COVID-19: two sides of the same coin","volume":"29","author":"Malavige","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.actatropica.2026.108266_bib0017","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41467-024-53916-9","article-title":"Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective","volume":"16","author":"Odio","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actatropica.2026.108266_bib0018","article-title":"Insights into dengue immunity from vaccine trials","volume":"15","author":"Ooi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actatropica.2026.108266_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005621","article-title":"Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children","volume":"11","author":"Prayitno","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108266_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006616","article-title":"Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia","volume":"12","author":"Sasmono","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108266_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.582235","article-title":"Distinct dengue disease epidemiology, clinical, and diagnosis features in Western, Central, and Eastern regions of Indonesia, 2017\u20132019","volume":"7","author":"Sasmono","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.actatropica.2026.108266_bib0022","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.actatropica.2026.108266_bib0023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue serostatus on Dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2026.108266_bib0024","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actatropica.2026.108266_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT50) in primary and secondary Dengue virus infections: how alterations in assay conditions impact performance","volume":"81","author":"Thomas","year":"2009","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"10.1016\/j.actatropica.2026.108266_bib0026","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2026.108266_bib0027","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1056\/NEJMoa2030243","article-title":"Efficacy of Wolbachia-infected mosquito deployments for the control of dengue","volume":"384","author":"Utarini","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2026.108266_bib0028","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1080\/21645515.2017.1333211","article-title":"Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination","volume":"13","author":"Vigne","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.actatropica.2026.108266_bib0029","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2026.108266_bib0031","unstructured":"World Health Organization, Dengue: guidelines for diagnosis, treatment, prevention and control. New Ed. Geneva: World Health Organization; https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b1db05d8-0e97-469e-b529-464dca6de540\/content."},{"key":"10.1016\/j.actatropica.2026.108266_bib0032","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1016\/j.vaccine.2021.07.042","article-title":"Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: a case-control study","volume":"39","author":"Ylade","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2026.108266_bib0034","first-page":"163","article-title":"Dengue and COVID-19 Co-infection or Cross-reactivity: Retrospective Study from a Tertiary Care Hospital","volume":"12","author":"Zubairy","year":"2021","journal-title":"Arch. Clin. Microbio."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26002998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26002998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:20:47Z","timestamp":1789633247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X26002998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S0001706X26002998"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108266","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing dengue antibodies after 10 years of the chimeric yellow fever tetravalent dengue vaccine (CYD-TDV) and dengue antibody cross-reactivity with SARS-CoV-2 in Indonesia","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108266"}}